Browse Guides  internal medicine  cardiology

Congestive heart failure

Prevalence
Causes
Clinical features
Differential diagnosis
Investigations
Therapy
Prevention
Prognosis
Prevention

There is no benefit from ibopamine a

Why?

  • Ibopamine kills patients a

Ibopamine increases mortality

Patient Treatment Comparison Outcome CER RRR
(95% CI)		 NNH
(95% CI)
severe heart failure a ibopamine  placebo death
at 12 months 		20% -20%
(-42% to -2%) 		24
(13 to 280)
      sudden death
at 12 months 		4.8% -50%
(-120% to -4%) 		41 (22 to 60)

 

Expiry date: June 2003
Levels of Evidence used in grading these guides

Author   CM   Ball
Reviewer   B   Lee
CAT Writers   CM   Ball , CJ   Wotton , A   Yates